Page last updated: 2024-11-05

n-methyl-4-aminoazobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methyl-4-aminoazobenzene: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12137
SCHEMBL ID5982612
MeSH IDM0046577

Synonyms (33)

Synonym
n-methyl-4-(phenylazo)benzenamine
n-methyl-4-aminoazobenzene
n-methyl-p-(phenylazo)aniline
aniline, n-methyl-p-(phenylazo)-
p-monomethylaminoazobenzene
4-(methylamino)azobenzene
ccris 382
4-monomethylaminoazobenzene
benzenamine, n-methyl-4-(phenylazo)-
n-methyl-p-aminoazobenzene
p-n-methylaminoazobenzene
MAB ,
n-methyl-4-phenyldiazenylaniline
M0143
621-90-9
AE-562/43459099
n-methyl-n-[4-(phenyldiazenyl)phenyl]amine
unii-44n974bfdi
44n974bfdi ,
SCHEMBL5982612
monomethylaminoazobenzene, 4-
n-methyl-4-[phenyldiazenyl]aniline #
p-(phenylazo)-n-methylaniline
DKOXITJAUZNAPK-FOCLMDBBSA-N
mfcd00059198
4-methylaminoazobenzene
(e)-n-methyl-4-(phenyldiazenyl)aniline
Q27889325
FT-0704252
n-methyl-4-(phenyldiazenyl)aniline
n-methyl-4-[(e)-2-phenyldiazen-1-yl]aniline
D91285
DTXSID201023342

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The levels of total MAB-DNA adducts in the liver were 2-10 times greater than in the kidney or spleen and appeared to increase 2- to 3-fold over the dosing period."( Characterization and properties of the DNA adducts formed from N-methyl-4-aminoazobenzene in rats during a carcinogenic treatment regimen.
Baetcke, KP; Dooley, KL; Kadlubar, FF; Miller, DW; Tullis, DL, 1987
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.45 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]